The largest database of trusted experimental protocols

Fnn0011

Manufactured by Merck Group
Sourced in Germany

FNN0011 is a laboratory equipment product manufactured by Merck Group. It is designed to perform a core function, but a detailed description while maintaining an unbiased and factual approach is not available.

Automatically generated - may contain errors

4 protocols using fnn0011

1

Western Blot Analysis of Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
After treatment, cells were harvested and lysed in the cell extraction buffer (Invitrogen, FNN0011) supplemented with proteasome inhibitor (P2714, Sigma) and 1 mM phenylmethanesulfonyl fluoride (PMSF). Equal amounts (20 µg) of protein were loaded onto SDS-PAGE for separation and then transferred onto a PVDF membrane. The membrane was blocked with 5% w/v nonfat dry milk (in TBS with 0.05% Tween-20). After incubation with the specific primary antibody (1:1000,5% nonfat dry milk or BSA in TBS with 0.05% Tween-20) at 4 °C overnight, the membrane was washed three times with TBST (TBS with 0.05% Tween-20) solution. The membrane was then incubated with secondary antibody (1:5000, in 5% nonfat dry milk, TBS with 0.05% Tween-20) at room temperature for 1 h followed by another three washes with TBST. The protein bands were developed by incubation with a luminescent reagent. ImageJ was used to quantify the band intensity.
+ Open protocol
+ Expand
2

Quantitative Western Blotting of CDH19

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting was performed as described 30 (link). Cells were lysed using cell extraction buffer (Invitrogen, FNN0011) containing protease inhibitor cocktail (Sigma Aldrich, P8340). Total protein was quantified using an EZQ Protein Quantification assay (Invitrogen, R33200). 30 μg of protein were resuspended in 2X reducing sample buffer (Invitrogen, LC2676), electrophoresed on 10-20% tris-glycine gels (Invitrogen), transferred using a semi-dry transfer system (Bio-Rad) to polyvinylidene difluoride membranes (PVDF) (Millipore), and probed with Ms-pAb-anti-CDH19 (Abnova, H00028513-B01P) at 1:250, identified at ∼114k kDa. Rb-pAb-anti-β-actin (Abcam, ab8227) at 1:2000 was used as loading control. Immunocomplexes were detected using luminescence Supersignal West Pico Substrate (Thermo Scientific) per manufacturer instructions.
+ Open protocol
+ Expand
3

Isolation of Brain Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary brain endothelial cells (BECs) were isolated from BACE1 knockout mice and littermate wildtype controls. The brains were minced and incubated in 0.2 mg/mL collagenase dispase dissolved in DMEM (1 h, 37 °C, 5% CO2). The samples were homogenised using a cannula attached to a stripette, strained in a 70 uL cell strainer, centrifuged (1000× g, 10 min at room temperature), and resuspended in 5 mL 20% BSA solution. The samples were centrifuged (1000× g, 20 min, room temperature) the myelin layer discarded and resuspended in 5 ml PBS before a final centrifuge (400× g, 5 min, room temperature). The pellet was resuspended in MV2 media (Promocell, Heidelberg, Germany; C-22022), supplemented with antibiotic antimycotic solution (Merck, Darmstadt, Germany; A5955-100ML), and cells incubated (37 degrees, 5% CO2) until confluent with the media changed every 2–3 days. We expect >95% of remaining cells to be BECs [76 (link)]. Cells were grown on 0.2% gelatine-coated plates. Once confluent, BECs were washed with ice cold PBS and lysed with a cell extraction buffer (Fisher Scientific, FNN0011) supplemented with protease inhibitor (Merck, Darmstadt, Germany).
+ Open protocol
+ Expand
4

hCMEC/D3 Cells Transfection and BACE1 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
hCMEC/D3 cells were grown on 0.2% gelatine-coated flasks/plates, and grown in ECGM2 (Endothelial Cell Growth Medium 2, Promocell) supplemented with antibiotic antimycotic solution (Merck, Darmstadt, Germany, A5955-100ML) at 37 degrees, and 5% CO2. For transfection, cells were plated on to 6-well plates at 100,000 cells per well and grown for 3 days. Cells were then transfected with 1ug of plasmid DNA of either empty vector (pcDNA3.1) or BACE1 per well, using Lipofectamine™ 2000 reagent (Invitrogen, Waltham, MA, USA), according to the manufacturer’s instructions. For BACE1-inhibitor treatments, cells were plated onto 6-well plates at 100,000 cells per well and grown for 3 days, and treated with Merck-3 (250 nM, Merck, Darmstadt, Germany) for 24 h. At 24 h post-transfection or inhibitor treatment, the cells were washed with ice cold PBS and lysed with a cell extraction buffer (Fisher Scientific, FNN0011) supplemented with protease inhibitor (Merck), or pelleted for RNA extraction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!